Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Clinical trial NCT07285213 · RECRUITING

Trial details

NCT number: NCT07285213
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridioides Difficile Infection

Start date: 2025-12-10
Primary completion: 2027-04-20
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.